In sum, our findings demonstrate that dPGC1 deregulation in cells with Yki activation leads to aberrant mitochondrial dynamics, increased Cyclin E levels, and DNA damage, factors that converge on key hallmarks of cancer, including altered cell proliferation, metabolism, and genomic instability. Here, YAP1 is linked to cancer.